Browse by Series:

Nivolumab Lung Cancer Approval Expanded, Abemaciclib Granted Breakthrough Status, and More

Laura Jones
Published: Friday, Oct 16, 2015

SELECTED
LANGUAGE
Slider Left
Slider Right
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Community Practice Connections™: Evolving Applications for PARP Inhibitors in Ovarian Cancer: Building on a Solid FoundationAug 15, 20191.5
Publication Bottom Border
Border Publication
x